DE602006017724D1 - Salicylsäurederivate - Google Patents
SalicylsäurederivateInfo
- Publication number
- DE602006017724D1 DE602006017724D1 DE602006017724T DE602006017724T DE602006017724D1 DE 602006017724 D1 DE602006017724 D1 DE 602006017724D1 DE 602006017724 T DE602006017724 T DE 602006017724T DE 602006017724 T DE602006017724 T DE 602006017724T DE 602006017724 D1 DE602006017724 D1 DE 602006017724D1
- Authority
- DE
- Germany
- Prior art keywords
- acid derivatives
- salicylic acid
- ono2
- bearing
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C203/00—Esters of nitric or nitrous acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73897805P | 2005-11-23 | 2005-11-23 | |
PCT/EP2006/068417 WO2007060112A1 (en) | 2005-11-23 | 2006-11-14 | Salicylic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006017724D1 true DE602006017724D1 (de) | 2010-12-02 |
Family
ID=37682661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006017724T Active DE602006017724D1 (de) | 2005-11-23 | 2006-11-14 | Salicylsäurederivate |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080293781A1 (de) |
EP (1) | EP1951653B1 (de) |
JP (1) | JP2009516719A (de) |
AT (1) | ATE485261T1 (de) |
CA (1) | CA2630805A1 (de) |
DE (1) | DE602006017724D1 (de) |
WO (1) | WO2007060112A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2679955A1 (en) * | 2006-10-13 | 2008-05-29 | Reliance Life Sciences Pvt. Ltd. | Novel chemotherapeutic agents against inflammation and cancer |
US8822509B2 (en) | 2006-12-29 | 2014-09-02 | The University Of Queensland | Pain-relieving compositions and uses therefor |
FR2921365B1 (fr) * | 2007-09-21 | 2012-10-12 | Servier Lab | Nouveaux sels d'addition d'inhibiteurs d'enzyme de conversion de l'angiotensine a des acides donneurs de no, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP2307013B1 (de) * | 2008-07-02 | 2016-02-24 | The University Of Queensland | Schmerzlindernde zusammensetzungen von furoxan-no-donatoren und ihre verwendungen |
WO2010081488A1 (en) * | 2009-01-15 | 2010-07-22 | Humanitas Mirasole S.P.A. | Nitric oxide furoxan derivative compounds endowed with antitumoral activity |
IT1398522B1 (it) * | 2010-02-23 | 2013-03-01 | Istituto Oncologico Veneto Irccs | Nuovi derivati furossanici idrosolubili aventi attivita' antitumorale. |
AU2011243947A1 (en) | 2010-04-23 | 2012-12-06 | Piramal Enterprises Limited | Nitric oxide releasing prodrugs of therapeutic agents |
CA2827887C (en) * | 2011-08-15 | 2020-06-09 | Research Foundation Of The City University Of New York | No- and h2s-releasing compounds |
CA2897571C (en) | 2013-01-21 | 2018-12-18 | Apparao Satyam | Nitric oxide releasing prodrugs of therapeutic agents containing at least one carboxylic acid group |
CN103848795B (zh) * | 2014-03-07 | 2016-08-17 | 山东大学 | 一种1,2,5-噁二唑-2-氧化物组蛋白去乙酰化酶抑制剂及其制备方法和应用 |
CN104592145B (zh) * | 2015-01-15 | 2017-05-17 | 山东大学 | 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用 |
JP7430879B2 (ja) | 2020-01-27 | 2024-02-14 | 学校法人君が淵学園 | アルブミン結合性を有するnoラジカル放出型抗がん剤としてのニトロ化フェニルカルボン酸誘導体 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19515970A1 (de) * | 1995-05-02 | 1996-11-07 | Bayer Ag | Acetylsalicylsäurenitrate |
IT1276071B1 (it) | 1995-10-31 | 1997-10-24 | Nicox Ltd | Compositi ad attivita' anti-infiammatoria |
IT1308633B1 (it) | 1999-03-02 | 2002-01-09 | Nicox Sa | Nitrossiderivati. |
IT1318673B1 (it) * | 2000-08-08 | 2003-08-27 | Nicox Sa | Farmaci per le disfunzioni sessuali. |
EP1219306A1 (de) * | 2000-12-29 | 2002-07-03 | Nicox S.A. | Zyklodextrin und NO-abgebende Arzneimittlen enthaltende Zusammensetzungen |
ITMI20011240A1 (it) | 2001-06-13 | 2002-12-13 | Nicox Sa | Farmaci per le vasculopatie |
ITMI20021392A1 (it) | 2002-06-25 | 2003-12-29 | Nicox Sa | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' |
ITMI20021399A1 (it) * | 2002-06-25 | 2003-12-29 | Nicox Sa | Inibitori della cicloossigenasi 2 |
WO2005030224A1 (en) | 2003-09-26 | 2005-04-07 | Nicox S.A. | Nitrosylated analgesic and/or anti-inflammatory drugs having antiviral activity |
-
2006
- 2006-11-14 US US12/094,655 patent/US20080293781A1/en not_active Abandoned
- 2006-11-14 CA CA002630805A patent/CA2630805A1/en not_active Abandoned
- 2006-11-14 EP EP06829984A patent/EP1951653B1/de not_active Not-in-force
- 2006-11-14 JP JP2008541695A patent/JP2009516719A/ja not_active Withdrawn
- 2006-11-14 DE DE602006017724T patent/DE602006017724D1/de active Active
- 2006-11-14 WO PCT/EP2006/068417 patent/WO2007060112A1/en active Application Filing
- 2006-11-14 AT AT06829984T patent/ATE485261T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE485261T1 (de) | 2010-11-15 |
EP1951653B1 (de) | 2010-10-20 |
CA2630805A1 (en) | 2007-05-31 |
US20080293781A1 (en) | 2008-11-27 |
EP1951653A1 (de) | 2008-08-06 |
JP2009516719A (ja) | 2009-04-23 |
WO2007060112A1 (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE485261T1 (de) | Salicylsäurederivate | |
ECSP067110A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica | |
EA201170772A1 (ru) | Органические соединения | |
EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
NO20071880L (no) | Diagnostic Compounds | |
TW200732323A (en) | Organic compounds | |
TW200621313A (en) | Pharmaceutical compositions | |
AR058348A1 (es) | Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden | |
UY32187A (es) | Composiciones farmaceuticas topicas | |
BRPI0620229A8 (pt) | formulação | |
CR9182A (es) | Derivado de quinolina, su uso, preparacion y medicamento que lo contiene | |
EP1831239B8 (de) | Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carbonsäure gamma-lacton und schlüsselzwischenprodukte für dieses verfahren | |
CR9391A (es) | Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
EA200870058A1 (ru) | Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран | |
NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner | |
ECSP088472A (es) | Derivados de 9-cloro-15-desoxiprostaglandina, procesos para su preparación y su uso como medicamento | |
EA200900780A1 (ru) | Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства | |
NO20074528L (no) | Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme | |
IL191670A0 (en) | Compounds for the inhibition of apoptosis | |
GB0615105D0 (en) | Novel compounds | |
AR060155A1 (es) | Combinaciones de principios activos con propiedades insecticidas y acaricidas | |
AR063597A1 (es) | Nueva sal | |
ATE537816T1 (de) | Leflunomid enthaltende pharmazeutische zusammensetzungen | |
TW200633717A (en) | Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents | |
ECSP088574A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica |